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2ABSTRACT
D-serine is an endogenous ligand for N-methyl D-aspartate (NMDA) receptors and alterations in 
its concentration have been related to several brain disorders, especially schizophrenia. It is 
therefore an important target neuromodulator for the pharmaceutical industry. To monitor D-
serine levels in vivo, we have developed a microbiosensor based on cylindrical platinum 
microelectrodes, covered with a membrane of poly-m-phenylenediamine (PPD), and a layer of 
immobilized D-amino acid oxidase from the yeast Rhodotorula gracilis (RgDAAO). By detecting 
the hydrogen peroxide produced by enzymatic degradation of D-serine, this microbiosensor 
shows a detection limit of 16 nM and a mean response time of 2 s. Interferences by ascorbic acid, 
uric acid, L-cysteine and by biogenic amines and their metabolites  are rejected at more than 97% 
by the PPD layer. Although several D-amino acids are potential substrates for RgDAAO, D-
serine was the only endogenous substrate present in sufficient concentration to be detected by our 
microbiosensor in the central nervous system. When implanted in the cortex of anesthetized rats, 
this microbiosensor detected the increase in concentration of D-serine resulting from its diffusion 
across the blood brain barrier after an intraperitoneal injection. This new device will make it 
possible to investigate in vivo the variations in D-serine concentrations occurring under normal 
and pathological conditions, and to assess the pharmacological potency of new drugs designed to 
impact D-serine metabolism.
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3Alterations in brain concentrations of D-serine, the predominant D-amino acid in the 
mammalian central nervous system1, have been recently related to several neurological and 
psychiatric diseases2. D-serine is synthesized in glial cells3 and neurons4, 5, through the 
racemization of L-serine by serine racemase3. It is released by astrocytes in response to chemical 
stimulation by glutamate, or glutamate receptor agonists such as -amino-3-hydroxy-5-
methylisoxazole-4-propionate (AMPA), kainic acid, or (1S,3R)-1-aminocyclopentane-1,3-
dicarboxylic acid (t-ACPD)6, 7. D-serine is an endogenous agonist of the glycine site of the N-
methyl-D-aspartate (NMDA) receptors8, and plays important roles in synaptic plasticity9, 10 and in 
several neurological and psychiatric disorders, such as schizophrenia11, 12, ischemia13,
Alzheimer’s disease14 and amyotrophic lateral sclerosis15. In particular, D-serine concentration is 
decreased in the cerebrospinal fluid of schizophrenic patients16, 17, and its administration 
enhances the therapeutic effects of known antipsychotic drugs18, 19. Notwithstanding the 
physiological importance of D-serine in these diseases, the variations in D-serine levels in the 
central nervous system (CNS) during behavior or pathological states remain largely unexplored. 
Also, the biochemical and cellular mechanisms controlling D-serine extracellular brain 
concentration are still elusive. To elucidate these important questions, the development of rapid 
and selective methods for monitoring D-serine dynamics in the brain is of paramount importance. 
Detection of free D-serine in the CNS has been reported using microdialysis20-23. Despite 
its impressive analytical power, microdialysis is limited by the large size of the probes used to 
collect brain samples and by the slow diffusion of molecules through the dialysis membrane. In 
particular, implantation of microdialysis probes into the CNS often causes lesions that impair the 
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4physiological processes taking place around the probe24-26. Moreover, microdialysis probes are 
too large to be inserted into brain slices or small structures of the rat or mouse CNS. 
To overcome these technical limitations, we developed an enzymatic microbiosensor 
capable of detecting D-serine in vivo. Enzymatic biosensors have been used for monitoring 
extracellular levels of neurotransmitters like glutamate27-31, adenosine32, adenosine tri-
phosphate33, choline34, 35, acetylcholine36-38, as well as metabolic molecules like glucose39 or 
lactate40. Moreover, D-amino acids (including D-serine) can be detected in food or beverages as 
markers of bacterial proliferation, using biosensors coated with the enzyme D-amino acid oxidase
(DAAO)41-44. However, these biosensors are too large to be inserted into the CNS of laboratory 
animals, and do not reach a sufficient detection limit to monitor physiological D-serine 
concentrations in the low micromolar range21. In this study, we sought to optimize this principle 
to achieve successful electrochemical D-serine detection in the brain.
Our microbiosensor is based on a platinum microelectrode (25×150 µm) covered with a 
membrane of poly-m-phenylenediamine (PPD) for selectivity, and with a layer of D-amino acid 
oxidase purified from the yeast Rhodotorula gracilis (RgDAAO). This microbiosensor detects D-
serine with an in vitro detection limit of 16 nM and a mean response time of 2.3 s. When used in 
the brain or in brain extracts, it is selective for D-serine over other endogenous amino acids or 
oxidizable molecules. Moreover, this microbiosensor can detect the basal D-serine extracellular 
concentration in the rat frontal cortex (3.1 µM) and D-serine diffusion through the blood brain 
barrier following an intraperitoneal injection. Parts of this study have been published in abstract 
form45.
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5EXPERIMENTAL SECTION
Preparation of the enzyme
Recombinant R. gracilis D-amino acid oxidase (RgDAAO, EC 1.4.3.3) was 
overexpressed in E. coli  and purified as reported by Molla et al.46. The final enzyme preparation 
had a specific activity of 55 U/mg protein on D-serine, and was concentrated up to 58 mg/ml of 
RgDAAO in a solution containing 25 mg/ml bovine serum albumin (BSA, Sigma, St-Quentin 
Fallavier, France) and glycerol (1%) in phosphate buffer (0.02 M, pH 8.5). Pig kidney DAAO 
was purchased from Sigma and prepared following the same protocol as RgDAAO.
Microbiosensor Preparation
Biosensors were constituted of a 25 µm diameter 90% Pt / 10% Ir wire (Goodfellow, 
Huntington, UK) glued to a 0.3 mm copper wire using electroconductive silver paint 
(Radiospares, Beauvais, France). It was then inserted into a pulled glass capillary (Harvard 
Apparatus, Edenbridge, UK) and the tip of the pipette was cut to let 150 µm of the platinum wire
protrude out of the glass. The junction between the platinum wire and the glass micropipette was 
sealed with epoxy resin (Araldite®, Bostik, Paris, France). The electrodes were then washed for
30 min in KOH 0.5 M and 20 min in ethanol. A PPD layer was electrodeposited by dipping the 
electrodes 20 minutes in a solution containing 100 mM m-phenylenediamine in PBS 0.01 M at 
pH 7.4 under a constant potential of +700 mV vs. an Ag/AgCl reference electrode. The enzyme 
layer was deposited by dipping the Pt tip of the electrodes in the DAAO solution (see above). 
Control microbiosensors (i.e. without DAAO) were produced by dipping the electrode in a 
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6solution of BSA (400 mg/ml) in phosphate buffered saline (PBS) 0.01 M, pH 7.4 and 1% 
glycerol. The enzyme was immobilized under saturated glutaraldehyde vapors for 120-135 s by 
placing the electrodes into a small chamber containing a few milliliters of a 50 % glutaraldehyde 
solution (under a fume hood because of the toxicity of glutaraldehyde vapors). Electrodes were 
then kept at -20°C in dry atmosphere for long-term storage.
All microbiosensors were tested for the detection of serotonin (5-HT, 20 µM in PBS), D-
serine (1 µM in PBS) and H2O2 (1 µM in PBS) before use. Only the electrodes showing more 
than 7 pA/µM D-serine and less than 4 pA/20 µM 5-HT were included in this study. To 
determine this threshold, we tested a total of 30 electrodes: D-serine sensitivity was 9.2 ± 3.4 
pA/µM and 16.7% were excluded using these criteria. 
Microbiosensors used for in vivo experiments were covered with an additional Nafion 
membrane, to protect the enzyme layer during penetration into the brain. The tip of the electrode 
was dipped 5 times in Nafion 1% (5% commercial solution from Aldrich, Saint Quentin 
Fallavier, France, diluted in isopropanol) and allowed to dry for at least 10 minutes at room 
temperature31, 34. This additional membrane did not change the sensitivity or the response time of 
the electrodes.
Recordings
All recordings were made either with a patch-clamp amplifier Geneclamp GC500 
(Molecular Devices, Sunnyvale, CA) or with an electrochemistry amplifier VA-10 (NPI 
Electronics, Tamm, Germany) used with a 2 electrode potentiostat. Data acquisition was 
performed with an ITC-18 acquisition board (Instrutech, Port Washington, NY) driven with a 
homemade software based on Igor Pro 5.0 procedures (Wavemetrics, Eugene, OR). The 
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7oxidation current was sampled at 1 kHz and averaged over 1000 data points, yielding a final 
sampling frequency of 1 Hz.
In vitro calibrations were performed in standard solutions prepared with phosphate 
buffered saline (0.01 M, pH 7.4). The reference electrode was a chlorided silver wire placed 
directly into the recording chamber. Recordings were made in constant potential amperometry at 
500 mV vs. the Ag/AgCl reference electrode. Calibration of the biosensors before and after in 
vivo experiments was performed in an artificial extracellular medium containing (in mM): NaCl 
126, KCl 1.5, KH2PO4 1.25, MgSO4 1.5, CaCl2 2 and HEPES 10 (pH 7.4). All chemicals were 
purchased from Sigma-Aldrich (Saint-Quentin Fallavier, France).
Preparation of brain samples
Male Wistar rats (300-400 g) were decapitated under isofurane anesthesia, and the 
forebrain was removed and homogenized in 5 ml of 5% trichloroacetic acid (TCA) to precipitate 
macromolecules. The homogenate was then centrifuged at 20 000 g for 10 min. TCA was 
extracted 6 times from the supernatant using ether, before lyophilization and storage at -20°C.
High pressure liquid chromatography (HPLC) measurements
Lyophilized brain extracts (40 mg) were dissolved in 1 ml deionized water, and 50 µl 
aliquots were treated with 0.8 mg N-acetyl-cysteine and 0.25 mg o-phthaldialdehyde in a 0.1M 
borate buffer, pH 10.4, for derivatization of amino acids. HPLC measurements were performed 
using a Waters Alliance instrument (Waters Corporation, Guyancourt, France) with a Waters 
symmetry column (4.6×250mm). The column and sample compartments were kept at 30 and 8°C 
respectively. Flow rate was set at 1 ml/min and run time was 20 min for all analyses. L- and D-
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8serine were eluted with an isocratic method using phase A (990 ml of 0.1 M sodium acetate and 
10 ml tetrahydrofurane, pH 6.2); the column was washed using phase B (500 ml of 0.1 M sodium 
acetate, 470 ml acetonitrile, 30 ml tetrahydrofurane, pH 6.2). Amino acid derivatives were 
detected using a Waters fluorescence detector (excitation 344 nm, emission 443 nm), and data 
were acquired using the Empower Pro software package (Waters Corporation, Guyancourt, 
France). Calibration of D-serine detection was performed using a 7-point standard curve.
In vivo experiments
Rats were anesthetized with a ketamine-xylazine mixture (42 mg/ml ketamine, 1,6 mg/ml
xylazine, purchased from Centravet, Plancoët, France, and injected at 0.2 ml/100 g body weight) 
and placed in a stereotaxic apparatus (Stoelting Corporation, Wood Dale, IL). Body temperature 
was kept at 37°C with a homeothermic blanket (LSI Letica, Barcelona, Spain). An active 
RgDAAO biosensor was implanted in the frontal cortex (1 mm lateral from the midline, 3 mm 
anterior from the bregma, 1.5 mm ventral from the dura), side by side (0.5 mm) with a control
biosensor covered with BSA. Both microbiosensors were covered with an additional Nafion 
layer. Before to start the recording, currents were allowed to stabilize for at least 30 min. D-serine 
1g/kg body weight was injected intraperitoneally after an additional 30 min period of control 
recording. In order to determine their selectivity and sensitivity, both biosensors were calibrated 
using 5-HT 20 µM and D-serine 1 µM dissolved in an artificial extracellular medium (see above) 
before and after the in vivo experiment.
Statistics
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9Data are expressed as mean ± standard deviation (SD) except for in vivo or brain extracts 
measurements, where we used mean ± standard error of the mean (SEM). Comparisons between 
two data groups were performed using the Student's t-test for equal or unequal variances, as 
determined by the F-test (significance level was p<0.05). Statistics software was the analysis 
tool-pack of Excel (Microsoft Office XP).
Page 9 of 35
ACS Paragon Plus Environment
Submitted to Analytical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
10
RESULTS AND DISCUSSION
Principle of D-serine detection by the biosensor
D-serine detection was achieved by a two-step reaction using the enzyme DAAO: (1) 
DAAO converts D-amino acids into their corresponding -ketoacids (hydroxypyruvate for D-
serine) and generates equimolar amounts of H2O2; (2) H2O2 is oxidized at the surface of a 
platinum wire connected to a patch-clamp amplifier (Fig 1). The resulting H2O2 oxidation current 
corresponds to the D-serine concentration in the biosensor’s microenvironment.
To optimize H2O2 detection by the microbiosensor, we generated cyclic voltammograms 
in a solution of H2O2 100 µM in PBS 0.01 M pH 7.4, using potential sweeps from 0 mV to 900 
mV vs. Ag/AgCl reference electrode. As described by other authors47, 48, holding potentials 
around 0 mV gave rise to electrochemical reduction of H2O2, whereas oxidation was achieved 
above +200 mV. Optimal H2O2 detection was performed at a holding potential of +500 mV vs. 
Ag/AgCl reference electrode, at which background currents were kept minimal. This value falls 
in the +500 mV and +700 mV range vs. Ag/AgCl reference electrode typically used for platinum 
wire enzymatic biosensors27, 33, 49, 50.
Choice of the DAAO
The most commonly used and commercially available DAAO is the one isolated from pig 
kidney (pkDAAO). Several biosensors for D-amino acids detection in food samples have been 
successfully prepared using pkDAAO41-44. However, these biosensors achieved detection limits 
in the 10-5-10-4 M range, which is not sufficient for detecting D-serine extracellular concentration 
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11
in the CNS, estimated at a few 10-6M20-22. This low sensitivity to D-amino acids might be due to 
the low specific activity of pkDAAO used for these biosensors. However, the DAAO from the 
yeast Rhodotorula gracilis shows better properties for biotechnological applications. It binds the 
flavin adenine dinucleotide (FAD) cofactor with high affinity and shows a higher specific activity 
and stability compared to its mammalian counterpart51.
We thus compared the sensitivity and selectivity of microbiosensors prepared with either 
pkDAAO or RgDAAO. Sensitivity for D-serine was 42% higher with RgDAAO microbiosensors 
than with pkDAAO ones: 9.2 ± 3.4 pA/µM (n=30) vs. 6.5 ± 2.0 pA/µM (n=4) respectively (Table 
1). Moreover, RgDAAO microbiosensors were more selective for D-serine than pkDAAO ones. 
For example, RgDAAO microbiosensors showed much smaller electrochemical responses to D-
aspartate (5.5% of the D-serine response vs. 38.6% for pkDAAO, n=4, Table 1) and were also 
slightly less sensitive to D-alanine (104 % of D-serine response vs. 165% for pkDAAO, n=4, 
Table 1). Because D-aspartate and D-alanine can also be found in the mammalian CNS, together 
with D-serine52, 53, the lower electrochemical responses produced by the RgDAAO biosensor to 
these D-amino acids would contribute to a greater selectivity in vivo. For these reasons, 
biosensors were prepared using RgDAAO in the rest of this study.
In vitro detection of D-serine
We first calibrated the RgDAAO microbiosensors in D-serine standard solutions. The 
electrodes responded to changes in D-serine concentration by a step increase in the recorded 
oxidation current (Fig. 2A). The response time of the microbiosensors, defined as the duration of 
the rise between 10% and 90% of the response, was 2 ± 1 s (n=5, Fig. 2B). 
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12
D-serine oxidation current showed a linear relationship with concentration from 100 nM
to 500 µM, with a sensitivity of 9.2 ± 3.4 pA/µM D-serine (n=25, Fig. 2C). Importantly, only the 
electrodes showing a sensitivity higher than 7 pA/µM D-serine were used for further studies (see 
Experimental section). When the recorded signal was averaged at 1 data point/s, the noise was 
about 0.05 pA, yielding a theoretical detection limit of 16 nM (signal/noise = 3). This detection 
limit is significantly lower than the estimated D-serine concentration in the CNS20-22 and is 
therefore compatible with in vivo detection of this D-amino acid.
Oxygen dependence
D-amino acid oxidases require O2 as a co-substrate to complete the catalytic cycle. In 
order to evaluate the dependence of D-serine detection on O2 concentration, we performed 
similar calibration experiments using PBS in equilibrium with the ambient atmosphere, or 
saturated with O2 or N2 (Fig. 2C-D). Provided that O2 is non-limiting, the relationship between 
the amplitude of the step in oxidation current detected by the biosensor and D-serine 
concentration can be approximated by a Michaelis-Menten equation:
(1)
where C is the oxidation current, and Cmax and Km,app are analogous to the classical Vmax
and Km kinetic parameters used for the equation of the free enzyme. In a O2-saturated medium, 
the response of the microbiosensor followed a Michaelis-Menten kinetics at least up to 2.5 mM 
D-serine with a Km,app of 3.62 ± 0.38 mM, and a Cmax of 54.2 ± 12.5 nA (n=4, Fig. 2D). Km,app
was significantly lower than the Km of the free enzyme in solution (13.75 mM51). Such a 
difference between free and immobilized RgDAAO was reported previously54, and was attributed 
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to the conformation of the immobilized enzyme and to a higher concentration of D-serine in the 
hydrophobic enzymatic layer compared to the solution (partitioning effect). When calibrated in 
air-equilibrated buffer, the microbiosensor yielded very similar responses to those obtained in O2
saturated medium (Fig. 2C-D). However, the calibration curve obtained in N2-saturated buffer 
deviated significantly from the ones obtained in the presence of O2 for D-serine concentrations 
greater than 30 µM (Fig. 2C-D). The oxidation current detected by the microbiosensor reached a 
plateau at about 8 nA, reflecting the decreased DAAO activity at low O2 concentrations. The 
calibrations in the 0-30 µM D-serine range show a weak dependence on pO2, like most 
biosensors based on the detection of enzymatically produced H2O227, 33, 55. This weak dependence 
on pO2 is probably due to O2-regeneration during H2O2 oxidation on the Pt surface, that produces
a concentration of O2 at which the rate of reoxidation of reduced DAAO is not limiting55. 
Because physiological D-serine concentrations in the CNS are expected around 5-10 µM20-22, D-
serine detection at our microbiosensor should not depend on local pO2, except, possibly, during 
pathological states like cerebral ischemia. 
pH and temperature dependence
D-serine detection by the biosensor showed the same pH dependence as RgDAAO in 
solution51, 56. The response at 10 µM D-serine increased from pH 5.4 to 8.0, reached a maximum 
at pH 8.0-8.5, and decreased at higher values (n=4, Fig. 3A). The response at physiological pH 
(7.4) was 80.7% of the maximum response observed at pH 8.5.
The temperature dependence of D-serine detection was also similar to that of the free 
enzyme in solution51. The microbiosensor response to D-serine increased with temperature, from 
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15°C to 40°C (n=4, Fig 3B). Its sensitivity at 37°C (in vivo temperature) is 75% higher than that 
at 25°C (room temperature). 
Operational and storage stability
The operational stability of the microbiosensors was estimated by placing the electrode in 
PBS and then adding 5 µM D-serine to produce an electrochemical signal. One hour later, the 
recording medium was replaced and fresh D-serine was newly added. The microelectrode 
response was thus evaluated every hour for 6 hours, during which it was almost constantly 
exposed to 5 µM D-serine. Under these conditions, response to D-serine remained stable (104 ± 4 
% of the initial sensitivity after 6h, n=4), indicating that (1) the enzyme was strongly fixed to the 
platinum wire and (2) the microbiosensor could be exposed to physiological D-serine 
concentrations for several hours without any alteration of its sensitivity.
Storage stability was evaluated for microbiosensors kept at -20°C immediately after 
manufacturing. Microbiosensors were tested for their response to 5 µM D-serine 8, 21, 28, 35, 84 
and 160 days after manufacturing. They were dried and frozen between each test. Response to D-
serine remained unchanged, showing only 2% loss in sensitivity after more than 160 days of 
storage (n=3). 
Selectivity
The preceding data demonstrate that our microbiosensor can reliably detect D-serine 
concentrations as low as a few tens of nM for several hours in standard solutions. However, in 
order to detect D-serine in complex biological media, it is necessary to achieve selective 
measurements avoiding the detection of other endogenous molecules present in vivo. Endogenous 
molecules can interfere in two ways: (1) direct oxidation on the surface of the platinum wire and 
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(2) oxidation by the enzyme accompanied by H2O2 production. Both kinds of interference were 
investigated:
1- Endogenous oxidizable molecules
The major endogenous molecules susceptible to oxidation at a platinum surface at +500 
mV vs. Ag/AgCl reference electrode are serotonin (5-HT) and its metabolite 5-
hydroxyindolacetic acid (5-HIAA), dopamine and its metabolite dihydroxyphenylacetic acid 
(DOPAC), L-cysteine, ascorbic acid and uric acid. Biosensors using enzymes directly coated on a 
bare platinum wire or carbon fiber typically produce strong interfering oxidation currents in 
response to physiological concentrations of these endogenous molecules. For example, 
microbiosensors consisting in RgDAAO directly deposited on a bare Pt wire showed such 
interfering responses (Fig. 4A). An efficient strategy to overcome these non-specific signals is to 
deposit a layer of electropolymerized PPD onto the Pt wire30, 39, 57, 58. This process is highly 
reproducible and generates a thin (10 nm), uniform membrane. The PPD layer forms a steric 
barrier that allows H2O2 diffusion but blocks larger molecules57, 59. Moreover, electropolymerized 
films of m-phenylenediamine show superior selectivity compared to those prepared with its p- or 
o- isomers30. RgDAAO microbiosensors manufactured from a poly-m-phenylenediamine covered 
Pt wire showed a dramatic reduction (97-99%) in the interfering responses produced by 
endogenous oxidizable molecules (n=4, Fig. 4B). By contrast, D-serine detection was only 
reduced by 12%.
We also tested the operational stability of the PPD layer. As shown in Fig. 4C, the small
response to 20 µM 5-HT remained stable for 6 hours (in PBS containing 5 µM D-serine at room 
temperature), indicating that the PPD layer retained its ability to reject 5-HT over several hours. 
However the PPD layer had a tendency to lose its selectivity over several days, even when stored 
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at -20°C. We found that it could be reactivated by dipping the microbiosensor for 1-2 s in a 100 
mM m-phenylenediamine solution, at 700 mV vs. Ag/AgCl reference electrode. This procedure 
barely affected the sensitivity of the microbiosensor and restored the original selectivity. Overall, 
these results show that interfering responses caused by endogenous oxidizable molecules are 
reduced by more than 97% by an electropolymerized film of m-phenylenediamine. Importantly, 
this selectivity layer decreases the responses to physiological concentrations of these interfering 
molecules to a negligible level compared to D-serine oxidation currents.
2- Other D-amino acids
Free RgDAAO in solution preferentially oxidizes neutral D-amino acids (such as D-
alanine, D-proline, D-cysteine, D-valine and D-serine), shows low activity towards basic ones 
and is practically inactive on acidic D-amino acids51. As expected, our RgDAAO 
microbiosensors generated large electrochemical responses not only to D-serine, but also to other 
D-amino acids, with the exception of D-aspartate and D-glutamate (6.5% and 1.7% respectively 
of the D-serine response at the same concentration, n=4, Fig. 5A). Glycine also generated very 
small responses (3.5% of D-serine response, n=4, Fig. 5A) whereas L-amino acids were not 
detected (<1.5% of D-serine response for L-serine and L-cysteine, n=4, Fig. 5A). Therefore, and 
consistent with earlier reports54, RgDAAO showed a broader substrate specificity when fixed on 
the microbiosensor than the free form, in particular, an increased activity towards basic amino 
acids.
In a recent study, Hamase et al.53 showed that D-serine was the predominant D-amino 
acid in the CNS, followed by D-aspartate (about 10% of D-serine contents), which is not detected 
by the microbiosensor, and by D-alanine (<3% of D-serine contents), which is a good substrate 
for RgDAAO (Fig. 5B). Therefore, the new RgDAAO microbiosensor would be selective for D-
Page 16 of 35
ACS Paragon Plus Environment
Submitted to Analytical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17
serine when used in the CNS, since interference from endogenous D-amino acids is negligible 
compared to D-serine signals.
Validation of the microbiosensor on brain extracts
To confirm the selectivity of the microbiosensor, we measured D-serine concentrations in 
brain extracts, comparing amperometric recordings and HPLC analysis. Both methods yielded 
comparable D-serine concentrations (130 ± 7 µM for HPLC vs. 139 ± 8 µM for the
microbiosensor, n=6, NS, Fig. 6C): amperometric detection using the microbiosensor differed 
from HPLC analysis by only 6%. To better quantify the amount of non-specific signals detected 
by the microbiosensor in the brain extracts, we eliminated D-serine (and other DAAO substrates) 
by incubating the sample for 2 hours with 20 U of RgDAAO and 200 U of catalase. This 
enzymatic treatment completely eliminated the D-serine peak in the HPLC chromatograms (Fig. 
6A) and reduced the amperometric signal by 95.0 ± 1.3% (n=6, p<0.01, Fig. 6B). This result 
confirms that the sum of interfering signals detected by the microbiosensor in brain extracts is 
about 5-6% of the D-serine signal, and that our RgDAAO microbiosensor specifically detects D-
serine when used in the CNS.
In vivo detection of D-serine
We then implanted our microbiosensors in the frontal cortex of anesthetized rats. The 
RgDAAO microbiosensor was implanted close to a control biosensor (devoid of DAAO) used to 
control for non-specific variations in oxidation current. Both microbiosensors were coated with 
an additional layer of Nafion to optimize biocompatibility (see Experimental Section).
Implantation in the CNS produced a small decrease in sensitivity (-13.2%, 10.05 ± 1.03 pA/µM 
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D-serine before, 8.72 ± 0.97 pA/µM after in vivo implantation, n=8). This decrease in sensitivity
is common to virtually all microbiosensors and generally occurs during the first 15 min following 
insertion into the brain60.
About 1 hr after implantation into the CNS, the background currents stabilized, showing a 
difference of 47.2 ± 7.5 pA (n=6) between the control and RgDAAO microbiosensor. This 
difference was not detected in calibrations made in PBS or in an artificial extracellular medium of 
ionic composition close to that of the rat cerebrospinal fluid (2.3 ± 1 pA, n=7). Because the 
control electrode and the RgDAAO microbiosensor were equally sensitive to endogenous 
oxidizable molecules like H2O2, ascorbate, etc., and because D-serine is the predominant D-
amino acid in the brain, the difference in background current mostly reflected the ambient basal 
D-serine concentration in the frontal cortex. To estimate the D-serine concentration represented 
by this difference in background currents, we calibrated our microbiosensors in artificial 
extracellular solution. In this medium, the sensitivity of the microbiosensor was unchanged 
compared to PBS. Moreover, addition of a physiological concentration (400 µM) of ascorbate in 
the recording medium did not change the sensitivity of the microbiosensor (n=3, data not shown). 
Using these calibration experiments, we estimated the basal extracellular D-serine concentration 
in the rat frontal cortex under ketamine-xylazine anesthesia at 3.1 ± 0.4 µM. This value is of the 
same order of magnitude as other estimations based on microdialysis experiments (6-8 µM)20-22.
We then injected 1 g/kg D-serine intraperitoneally. It induced a steady increase in 
oxidation current at the RgDAAO microbiosensor, but not at the control sensor, indicating that 
the electrochemical signal detected by the RgDAAO microbiosensor was specific for D-serine. 
This increase in electrochemical signal was most probably due to the diffusion of D-serine across 
the blood-brain barrier. Three hours after the injection, the increase in oxidation current at the 
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RgDAAO microbiosensor was 65.3 ± 14.2 pA whereas the background current at the control
microbiosensor decreased by 5.8 ± 1.8 pA (n=6, Fig. 7). Using the same calibration experiments 
in artificial cerebrospinal fluid, we estimated that the D-serine extracellular concentration
increased by 4.8 µM, to reach a final 7.9 ± 1.2 µM at the end of the 3 hour recording following 
the peripheral injection. This modest increase in D-serine concentration is in agreement with 
previous measurements made post-mortem on whole tissue61. However, these data contrast with 
an earlier report using microdialysis, that showed a much faster 6-fold increase in D-serine levels 
following the intraperitoneal injection of a smaller dose of D-serine (50 mg/kg)62. Indeed,
implantation of microdialysis probes in the brain usually produces significant tissue damage, 
especially to neighboring blood vessels24, 25. This problem might have led to an overestimation of 
D-serine diffusion into the brain. In this respect, biosensors of micrometric size seem preferable 
for studies requiring integrity of the blood-brain barrier25. In particular, the slow and modest
increase in D-serine levels detected by our microbiosensors after the peripheral D-serine 
injection, suggests that damage to the blood-brain barrier produced upon implantation of the 
electrodes in the frontal cortex was indeed minimal.
Conclusion
Overall, these data demonstrate that D-serine levels in the CNS can be monitored using 
platinum-wire microbiosensors coated with the enzyme RgDAAO. This is the first report, to our 
knowledge, showing successful detection of D-serine concentrations in vivo at the micromolar 
level using an amperometric biosensor. Compared to previous DAAO biosensors used for D-
amino acid detection in food, D-serine detection in vivo requires an increased selectivity, a higher 
sensitivity, and miniaturization to allow implantation in the CNS of small laboratory animals. 
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These technical challenges have been overcome through (1) the use of RgDAAO, a more active 
and more selective enzyme than the previously used pkDAAO, (2) the development of 
micrometric platinum wire electrodes for H2O2 monitoring, and (3) the use of a highly selective 
PPD layer to block the non-specific oxidation of endogenous oxidizable molecules.
This new device will now pave the way for a better understanding of the physiological 
and pathological situations that lead to changes in D-serine levels in the CNS as well as the 
cellular mechanisms of D-serine release and elimination. It will also provide a powerful 
analytical tool for screening new pharmacological agents designed to modify D-serine 
metabolism in the CNS, in order to improve current treatments for neurological and psychiatric 
disorders such as schizophrenia62.
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Table 1
pKDAAO microbiosensor RgDAAO microbiosensor
Substrate Sensitivity 
(pA/µM)
% of D-serine 
detection
Sensitivity 
(pA/µM)
% of D-serine 
detection
D-Ser 6.5 ± 2.0 100% 9.2 ± 3.4 100%
D-Asp 2.5 ± 0.8 38.6% 0.5 ± 0.2 5.5%
D-Ala 10.8 ± 2.9 165% 9.6 ± 1.4 104%
Table 1: Response of microbiosensors produced with pkDAAO or RgDAAO on 
different D-amino acids. Sensitivity to D-serine, D-aspartate and D-alanine were assessed for 
the two microbiosensors. RgDAAO microbiosensors show greater sensitivity and improved 
selectivity for D-serine compared to pkDAAO ones (n=4).
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Figure 1: Design of the biosensor. A. Photomicrograph of the tip of a RgDAAO 
microbiosensor. The enzymatic layer appears as a translucid, yellow membrane. B. 
Schematic representation of the D-amino acid oxidase (RgDAAO) microbiosensor. A 
platinum wire is covered with a layer of poly-m-phenylenediamine (PPD) and an 
enzymatic membrane of RgDAAO. C. Enzymatic reaction allowing D-serine detection at 
the microbiosensor: D-serine is oxidized into hydroxypyruvate by RgDAAO with equimolar 
production of hydrogen peroxide (H2O2) that diffuses through the PPD layer and is 
oxidized by the platinum wire. H2O2 oxidation gives rise to two electrons detected by the 
patch-clamp amplifier. 
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Figure 2: D-serine detection. A. Response of the biosensor to changes in D-serine 
concentration. The electrode was rapidly transferred from phosphate buffered saline 
(PBS) to a 500 nM or 1 (M D-serine solution and back to PBS. The change in D-serine 
concentration was detected as a step in the oxidation current recorded by the electrode 
B. Response time. The electrode was switched from 0 to 10 (M D-serine. The response 
time was defined as the time between 10% and 90% of the current step. In order to 
obtain a higher time resolution, the signal was averaged over 10 ms (instead of 1 s) C. 
Calibration curves of a microbiosensor at three oxygen concentrations (N2-saturation, air 
equilibrated and O2-saturation) in the 0-50 (M D-serine concentration range. Except for 
the N2-saturated medium, the oxidation current shows a linear dependence on the D-
serine concentration. D. Calibration curves of the microbiosensor in the 0-2.5 mM D-
serine concentration range. The calibration was made in N2-saturated, in air equilibrated
and in O2-saturated PBS. The relationship between the oxidation current and D-serine 
concentration fits with a classical Michaelis-Menten equation in which O2 is not-limiting 
in catalysis. 
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Figure 3: pH and temperature dependence. A. pH-dependence of D-serine detection. pH 
was adjusted in 0.01 M PBS from 5.4 to 8.0 and 0.01 M borate from 8.3 to 11.5. Data are 
expressed as a percentage of the response at pH 8.0 (n=4). B. Temperature-dependence 
of the microbiosensor response (n=4). All measurements were performed in 10 ,M D-
serine, PBS 0.01M, pH 7.4. 
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Figure 4: Selectivity of the biosensor. Responses of the biosensor to physiological 
concentrations of different interfering molecules present in the CNS, without (A) and with 
(B) the PPD layer (n=4). The PPD layer dramatically decreased the sensitivity of the 
biosensor to interfering substances. C. Stability of the PPD layer. Electrochemical 
responses to 5-HT remained low for at least 6 hours of in vitro experiment at room 
temperature (n=4, measuring conditions: PBS 0.01 M, pH 7.4).  
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Figure 5: Detection of other amino acids. A. Detection of the D-isomers of the 20 standard 
amino acids, as well as glycine, L-serine and L-cysteine (10 !M). Data are expressed as a 
percentage of the response obtained with 10 !M D-serine (n=4). As expected from the 
biochemical properties of RgDAAO, the biosensor detected all D-amino acids that we 
tested, except D-aspartate and D-glutamate. Glycine and L-amino acids produced 
negligible responses. B. Amounts of the most abundant D-amino acids in the mouse brain
as reported by Hamase et al53. The predominant D-amino acid is D-serine (red), followed 
by D-aspartate (blue) and D-alanine (green). 
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Figure 6: D-serine detection in brain extracts. A. Example chromatogram showing 
separation between D-serine (elution time = 12 min) and L-serine (= 13 min). The D-
serine peak completely disappeared after incubation with RgDAAO and catalase. B. 
Example of electrochemical responses recorded by the microbiosensor upon addition of a 
brain extract (40× dilution) and 3 -M D-serine. The response almost disappeared when 
the brain extract was preincubated with RgDAAO and catalase. C. Summary of the results 
of D-serine concentrations in brain extracts estimated by HPLC and the RgDAAO 
biosensor. Both techniques yielded comparable results, thus indicating an excellent 
selectivity for D-serine in brain extracts. * significant difference with D-serine levels 
following DAAO incubation (p<0.05). Data are expressed as mean ±SEM (n=6). 
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Figure 7: D-serine detection in vivo. Effect of an intraperitoneal injection of D-serine (1 
g/kg body weight) on the electrochemical signal detected in the frontal cortex by a 
RgDAAO microbiosensor and a control (BSA) microbiosensor implanted in its vicinity 
(about 0.5 mm). Background currents were systematically higher at the RgDAAO 
microbiosensor compared to the control electrode, revealing a detectable basal 
extracellular D-serine concentration. Peripheral D-serine injection produced a specific 
increase in oxidation current at the RgDAAO microbiosensor, reflecting D-serine diffusion 
across the blood brain barrier. Data are expressed as mean (solid line) ±SEM (shading) of 
6 experiments. 
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